UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

The Pharmaceutical Price Regulation Scheme (PPRS) came into force in January 2014, and involved the UK industry effectively ... second part of Sarah Rickwood's overview of the UK market will ...

We asked Tom Delahoyde, managing director at Chiesi UK & Republic of Ireland, his thoughts on the industry’s role in achieving a sustainable future. Why is the pharmaceutical industry so ...

The UK government plans to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% of subject ...

The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the Association of the British Pharmaceutical Industry (ABPI). As one of the ...

The UK pharmaceutical intermediate market is on a steady growth trajectory, expected to reach USD 1,156.0 million in 2025 and expand to USD 1,553.2 million by 2035, reflecting a compound annual growth ...

The UK has announced plans to abolish NHS England and integrate its functions into the central government, marking a ...

Novo Nordisk A/S (NYSE:NVO) returned to full membership of the Association of the British Pharmaceutical Industry (ABPI) ...

Pharma and Biopharma is a trillion-dollar industry providing ample career opportunities for laboratory scientists and entrepreneurs. Join Principal Consultant Michael W. Dong of MWD Consulting as he ...

The number of deals in the UK healthcare mergers & acquisition (M&A ... according to a report by investment firm Heligan Group. As in previous years, pharma and life sciences were the most active ...